RootPath
Cambridge
About RootPath
RootPath is a Cambridge-based biotechnology company developing a powerful personalized T cell therapy platform that bridges precision medicine and cancer immunotherapy. Their next generation technologies allow us to precisely monitor, modulate and steer the immune system for a revolution in the diagnosis and treatment of cancer.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: Less than $1M
- Total funding: $69.4M
- Last round: Series Unknown (Apr 2025)
- Website: rootpath.com
- Phone: [email protected]
Industries & Categories
Biotechnology, Precision Medicine
Social Profiles
Canonical: https://fsome.com/organization/rootpath-36580 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.